We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Approves Alexion Drug for Rare Disorder
The FDA approved Alexion Pharmaceuticals’enzyme replacement drug Kanuma for an ultra rare disorder known as lysosomal acid lipase deficiency in pediatric and adult patients.